Ocrelizumab significantly reduced the number and volume of cortical lesions associated with multiple sclerosis at 120 weeks, ...

Healio quotes Michael Dwyer in an article about a drug, Ocrelizumab, that significantly reduced the number and volume of cortical lesions associated with multiple sclerosis. “Gray matter is ...

exfoliating skin lesions that itched and burned. After undergoing months of treatment with traditional therapies for erythroderma, which included the steroid prednisone, anti-itch creams ...

The study, published today in JAMA Neurology by a team at King's College London and University College London (UCL), shows how the tool significantly improves the detection of focal cortical ...

2025 — A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a ...

The study, published in JAMA Neurology by a team at King's College London and University College London (UCL), shows how the tool significantly improves the detection of focal cortical dysplasias ...

Multiple sclerosis (MS) causes a specific type of ... When a damaged area is visible on a scan, it is known as a lesion. Sometimes, people with MS remain in a stable condition, others experience ...

If your doctor thinks you may have multiple sclerosis, an MRI can help them ... Sometimes, these changes are described as lesions. The appearance of demyelination (damage to the myelin that ...